Regentis Biomaterials Ltd. (RGNT) — SEC Filings
Regentis Biomaterials Ltd. (RGNT) — 2 SEC filings. Latest: 6-K (Dec 18, 2025). Sentiment: bullish. Includes 2 6-K. Overall sentiment: bullish.
View Regentis Biomaterials Ltd. on SEC EDGAR
Overview
Regentis Biomaterials Ltd. (RGNT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 18, 2025: Regentis Biomaterial Ltd. announced on December 18, 2025, that it has been granted a new U.S. patent for its GelrinC product, an off-the-shelf regenerative cartilage repair solution. This patent is expected to strengthen the company's intellectual property portfolio for its innovative medical device
Sentiment Summary
Across 2 filings, the sentiment breakdown is: 1 bullish, 1 neutral. The dominant filing sentiment for Regentis Biomaterials Ltd. is bullish.
Filing Type Overview
Regentis Biomaterials Ltd. (RGNT) has filed 2 6-K with the SEC between Dec 2025.
Recent SEC Filings (2)
| Date | Form | Description | Risk |
|---|---|---|---|
| Dec 18, 2025 | 6-K | Regentis Biomaterials Secures New U.S. Patent for GelrinC | low |
| Dec 5, 2025 | 6-K | 6-K Filing |
Risk Profile
Risk Assessment: Of RGNT's 1 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 1 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Top Tags
patent (1) · intellectual-property (1) · medical-device (1)
Frequently Asked Questions
What are the latest SEC filings for Regentis Biomaterials Ltd. (RGNT)?
Regentis Biomaterials Ltd. has 2 recent SEC filings from Dec 2025, including 2 6-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of RGNT filings?
Across 2 filings, the sentiment breakdown is: 1 bullish, 1 neutral. The dominant sentiment is bullish.
Where can I find Regentis Biomaterials Ltd. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Regentis Biomaterials Ltd. (RGNT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Regentis Biomaterials Ltd.?
Financial highlights for Regentis Biomaterials Ltd. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for RGNT?
Investment thesis data for RGNT will be available once enriched filings are processed.
Who are the key executives at Regentis Biomaterials Ltd.?
Executive information for Regentis Biomaterials Ltd. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Regentis Biomaterials Ltd. stock?
Of RGNT's 1 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Regentis Biomaterials Ltd.?
Forward guidance and predictions for Regentis Biomaterials Ltd. are extracted from SEC filings as they are enriched.